China’s Legislature Passes the New Drug Administration Law

Published date03 September 2019
Subject MatterLife Sciences,China,Manufacturers,Counterfeit Drugs,Cross-Border Transactions,Drug Safety,Orphan Drugs,Research and Development,Pharmaceutical Industry,Food and Drug Administrations
AuthorKatherine Wang
Law FirmRopes & Gray LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT